Tech Company Financing Transactions
Vaccsys Funding Round
Vaccsys closed a $9 million Series A investment round on 6/18/2008. Backers included Alta Partners, The Column Group and Versant Ventures.
Transaction Overview
Company Name
Announced On
6/18/2008
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Series A
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
1124 Columbia St 402
Seattle, WA 98104
USA
Seattle, WA 98104
USA
Phone
Website
Email Address
Overview
The company is developing vaccines that regulate immune responses by targeting dendritic cell biology with combinations of proprietary vectors and adjuvants.
Management Team
Browse more venture capital transactions:
Prev: 6/18/2008: DynaPump venture capital transaction
Next: 6/18/2008: ParaScale venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs